Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alaris Medical Systems

This article was originally published in The Gray Sheet

Executive Summary

U.K. Medical Devices Agency warns of possible over-infusion from Alaris' P1000, P2000, P3000 lines of syringe pumps due to obsolete software related to volume limit and bolus features, as well as a typographical error in product labeling. Clinicians are advised to contact Alaris for upgraded software, and to attach an interim label correcting the error. "The most serious effect of this error, if not detected by the user, is over-infusion due to the pump running at the Keep Vein Open rate instead of automatically stopping once the volume limit is reached," MDA states in Oct. 23 notice

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel